Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (36)
Blood Cancer Journal (35)
Bone Marrow Transplantation (15)
Nature (1)
Scientific Reports (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (64)
Correspondence (12)
Amendments and Corrections (10)
Editorial (2)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Cell biology
Chemical biology
Diseases
Genetics
Health care
Immunology
Medical research
Oncology
Risk factors
Signs and symptoms
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 89 results

Advanced filters: Author: Wilson Gonsalves Clear advanced filters

Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma

Saurabh Zanwar
Dragan Jevremovic
Shaji Kumar
ResearchOpen Access03 Jan 2026
Blood Cancer Journal

Volume: 16, P: 1-6
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

G. N. Rogers
J. C. Paulson
D. C. Wiley
Research01 Jul 1983
Nature

Volume: 304, P: 76-78
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis

Saurabh Zanwar
Gokce Belge Bilgin
Shaji Kumar
Research28 Sept 2025
Leukemia

Volume: 39, P: 2866-2871
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes

Tamer Hellou
Daniel G. Packard
Morie A. Gertz
ResearchOpen Access29 Sept 2025
Blood Cancer Journal

Volume: 15, P: 1-6
Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemia

Tamer Hellou
Shaji K. Kumar
Wilson I. Gonsalves
CorrespondenceOpen Access27 Dec 2025
Blood Cancer Journal

Volume: 15, P: 1-4
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma

Saurabh Zanwar
Dragan Jevremovic
Shaji Kumar
ResearchOpen Access18 Feb 2025
Blood Cancer Journal

Volume: 15, P: 1-6
Capillary leak phenotype as a major cause of death in patients with POEMS syndrome

Kenzie Lee
Taxiarchis Kourelis
Angela Dispenzieri
ResearchOpen Access16 Dec 2024
Leukemia

Volume: 39, P: 703-709
Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance

Joel-Sean Hsu
Udit Yadav
Richard K. Kandasamy
CorrespondenceOpen Access21 Nov 2025
Blood Cancer Journal

Volume: 15, P: 1-4
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide

Utkarsh Goel
Charalampos Charalampous
Shaji K. Kumar
ResearchOpen Access26 Mar 2024
Blood Cancer Journal

Volume: 14, P: 1-6
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma

Walker M. Schmidt
Nirosha D. Perera
Morie A. Gertz
ResearchOpen Access18 Aug 2023
Blood Cancer Journal

Volume: 13, P: 1-8
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience

Sarah Goldman-Mazur
Alissa Visram
Shaji K. Kumar
ResearchOpen Access06 Dec 2022
Blood Cancer Journal

Volume: 12, P: 1-6
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

Carlos Fernández de Larrea
Robert Kyle
Maria Victoria Mateos
ResearchOpen Access02 Dec 2021
Blood Cancer Journal

Volume: 11, P: 1-5
Mortality trends in multiple myeloma after the introduction of novel therapies in the United States

Moritz Binder
Bharat Nandakumar
Shaji K. Kumar
Research26 Oct 2021
Leukemia

Volume: 36, P: 801-808
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis

Alissa Visram
S. Vincent Rajkumar
Shaji Kumar
ResearchOpen Access26 Nov 2021
Blood Cancer Journal

Volume: 11, P: 1-8
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients

Patrick W. Mellors
Surendra Dasari
Angela Dispenzieri
ResearchOpen Access04 Mar 2021
Blood Cancer Journal

Volume: 11, P: 1-9
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation

Abdullah S. Al Saleh
Mohammad S. Ebraheem
Morie A. Gertz
ResearchOpen Access11 Apr 2022
Blood Cancer Journal

Volume: 12, P: 1-6
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

Praful Ravi
Shaji K. Kumar
S. Vincent Rajkumar
ResearchOpen Access15 Nov 2018
Blood Cancer Journal

Volume: 8, P: 1-6
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

Eli Muchtar
Morie A. Gertz
Angela Dispenzieri
Research22 Nov 2019
Leukemia

Volume: 34, P: 1135-1143
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

Iuliana Vaxman
Alissa Visram
Morie A. Gertz
Research04 Dec 2020
Bone Marrow Transplantation

Volume: 56, P: 1144-1150
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma

Kevin C. Miller
Morie A. Gertz
Shaji K. Kumar
Research16 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 587-594
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

Ashley Paquin
Alissa Visram
S. Vincent Rajkumar
ResearchOpen Access28 Aug 2020
Blood Cancer Journal

Volume: 10, P: 1-7
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis

Iuliana Vaxman
M. Hasib Sidiqi
Morie Gertz
Research18 Nov 2020
Bone Marrow Transplantation

Volume: 56, P: 928-935
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

Abdullah S. Al Saleh
M. Hasib Sidiqi
Morie A. Gertz
Research01 May 2020
Bone Marrow Transplantation

Volume: 55, P: 2132-2137
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis

Nadine Abdallah
Surbhi Sidana
Shaji Kumar
Research09 Jun 2020
Bone Marrow Transplantation

Volume: 55, P: 1297-1304
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

Ashley R. Paquin
Shaji K. Kumar
S. Vincent Rajkumar
ResearchOpen Access11 Dec 2018
Blood Cancer Journal

Volume: 8, P: 1-7
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

M Hasib Sidiqi
Mohammed A. Aljama
Morie A. Gertz
Research07 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 442-447
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

M. Hasib Sidiqi
Mohammed A. Aljama
Morie A. Gertz
ResearchOpen Access08 Nov 2018
Blood Cancer Journal

Volume: 8, P: 1-8
Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

Yi L. Hwa
Morie A. Gertz
Angela Dispenzieri
Research08 Feb 2019
Leukemia

Volume: 33, P: 1268-1272
Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function

M. Hasib Sidiqi
Kalyan Nadiminti
Morie A. Gertz
Research08 Apr 2019
Bone Marrow Transplantation

Volume: 54, P: 1775-1779
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

Surbhi Sidana
Nidhi Tandon
Shaji K. Kumar
Research15 Oct 2018
Leukemia

Volume: 33, P: 730-738
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

Gaurav Goyal
S. Vincent Rajkumar
Shaji K. Kumar
Research20 Feb 2019
Leukemia

Volume: 33, P: 1273-1277
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation

M. Hasib Sidiqi
Mohammed A. Aljama
Morie A. Gertz
Research02 Nov 2018
Bone Marrow Transplantation

Volume: 54, P: 1077-1081
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

Angela Dispenzieri
Bonnie Arendt
David Murray
ResearchOpen Access25 Feb 2020
Blood Cancer Journal

Volume: 10, P: 1-5
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

M. Hasib Sidiqi
Mohammed Aljama
Angela Dispenzieri
ResearchOpen Access06 May 2020
Blood Cancer Journal

Volume: 10, P: 1-9
Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect

Wiese et al. find that oxaloacetate generated through increased activation of PKM2 can inhibit lactate dehydrogenase A, shedding light on the long observed PKM2 paradox during Warburg metabolism in cancer cells.

Elizabeth K. Wiese
Sadae Hitosugi
Taro Hitosugi
Research05 Jul 2021
Nature Metabolism

Volume: 3, P: 954-968
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

Surbhi Sidana
Nidhi Tandon
Shaji K. Kumar
Research21 Dec 2017
Bone Marrow Transplantation

Volume: 53, P: 326-333
Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset

Gaurav Goyal
Adam C. Bartley
Wilson I. Gonsalves
Research21 Mar 2018
Leukemia

Volume: 32, P: 1414-1420
Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

Surbhi Sidana
Nidhi Tandon
Wilson I. Gonsalves
Research21 Feb 2018
Leukemia

Volume: 32, P: 1421-1426
Interleukin-6 is a highly prognostic biomarker for POEMS syndrome

Joselle Cook
Rahma Warsame
Angela Dispenzieri
ResearchOpen Access11 Jul 2025
Leukemia

Volume: 39, P: 2281-2284
Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia

Arwa Bohra
Rafla Hassan
Shaji Kumar
Research26 May 2025
Leukemia

Volume: 39, P: 2039-2041
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis

Elham Askari
Angela Dispenzieri
Shaji K. Kumar
ResearchOpen Access07 Aug 2025
Blood Cancer Journal

Volume: 15, P: 1-11
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Wilson I. Gonsalves
Francis K. Buadi
Vivek Roy
ReviewsOpen Access09 Jul 2018
Bone Marrow Transplantation

Volume: 54, P: 353-367
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes

Abiola Bolarinwa
Madhu Nagaraj
Shaji Kumar
ResearchOpen Access04 Apr 2025
Blood Cancer Journal

Volume: 15, P: 1-7
Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma

Wilson I. Gonsalves
Katarzyna Broniowska
Shaji K. Kumar
ResearchOpen Access24 Jun 2020
Scientific Reports

Volume: 10, P: 1-11
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures

Saurabh Zanwar
Morie A. Gertz
Angela Dispenzieri
ResearchOpen Access09 Apr 2024
Leukemia

Volume: 38, P: 1423-1426
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100

Alissa Visram
S. Vincent Rajkumar
Shaji K. Kumar
Amendments and Corrections02 Jul 2024
Leukemia

Volume: 38, P: 1862
Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis

Alissa Visram
Celine Vachon
Shaji Kumar
Amendments and Corrections17 Jun 2024
Leukemia

Volume: 38, P: 1865
Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment

Jean-Sébastien Claveau
David L. Murray
Shaji K. Kumar
Amendments and Corrections17 Jun 2024
Leukemia

Volume: 38, P: 1863
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab

Nadine Abdallah
David Murray
Shaji Kumar
Amendments and CorrectionsOpen Access17 Jun 2024
Leukemia

Volume: 38, P: 1864
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

Matthew J. Rees
Aytaj Mammadzadeh
Shaji Kumar
ResearchOpen Access23 Jul 2024
Blood Cancer Journal

Volume: 14, P: 1-9